Article
Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen.
Cancer immunology, immunotherapy : CII - 1 May 2013
Cannon Martin J, Goyne Hannah E, Stone Pamela J B, Macdonald Laura J, James Lindsey E, Cobos Everardo, Chiriva-Internati Maurizio
Abstract excerpt
The recent finding that Th17 infiltration of ovarian tumors positively predicts patient outcomes suggests that Th17 responses play a protective role in ovarian tumor immunity. This observation has led to the question of whether Th17 cells could be induced or expanded to therapeutic advantage by tumor vaccination. In this study, we show that treatment of ovarian tumor antigen-loaded, cytokine-matured human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
